A loading dose of teicoplanin in critically ill patients: effectiveness of dosing determined by data analysis software.

A loading dose of teicoplanin in critically ill patients: effectiveness of dosing determined by data analysis software. - A loading dose of teicoplanin with data analysis software.

Status

Unknown

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002149

Enrollment

Registered

2009-08-01

Start date

2007-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gram-positive infections

Interventions

initial loading dose of teicoplanin is determined by a data analysis software 400 mg of teicoplanin is administered for loading dose every 12 h three times and following 24 h.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: diagnosed or suspected of Gram-positive infections in our intensive care unit

Exclusion criteria

Exclusion criteria: hemodialysis therapy, infective endocarditis and purulent osteomyelitis.

Design outcomes

Primary

Measure	Time frame
trough concentration of teicoplanin at 24, 48, 72hrs after first administration.	—

Secondary

Measure	Time frame
The duration of ICU stay and mortality rate	—

Countries

Japan

Contacts

Public ContactHideaki Imanaka

Tokushima University Hospital Emergency and Critical Care Medicine

imanakah@clin.med.tokushima-u.ac.jp0886339347

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026